Envestnet Asset Management Inc Regenxbio Inc. Transaction History

Envestnet Asset Management Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	SELL	$18.08 - $24.55 $36,847 - $50,032	-2,038 Reduced 6.14%	31,175 $589,000
Q4 2022 Feb 07, 2023	BUY	$20.4 - $24.73 $131,029 - $158,840	6,423 Added 23.98%	33,213 $753,000
Q3 2022 Nov 10, 2022	BUY	$22.29 - $35.04 $292,823 - $460,320	13,137 Added 96.22%	26,790 $708,000
Q2 2022 Aug 03, 2022	BUY	$19.35 - $35.04 $100,039 - $181,156	5,170 Added 60.95%	13,653 $337,000
Q1 2022 May 04, 2022	BUY	$24.62 - $34.31 $19,794 - $27,585	804 Added 10.47%	8,483 $282,000

Q4 2021 Feb 04, 2022	BUY	$30.19 - $40.28 $22,491 - $30,008	745 Added 10.74%	7,679 $251,000
Q3 2021 Oct 07, 2021	BUY	$29.09 - $45.68 $201,710 - $316,745	6,934 New	6,934 $291,000

193

42.1M

80.6K

55.2K

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $460M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Envestnet Asset Management Inc with notifications on news.